Effect of Kidney Replacement Therapy with Polymethylmethacrylate Membranes on Pruritus-related Quality of Life in Patients Receiving Maintenance Haemodialysis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSaint Petersburg State University, Russia

About this trial

This randomized controlled trial aims to evaluate the effect of polymethylmethacrylate dialysis membranes use on the intensity of pruritus in patients with CKD stage 5D receiving maintenance hemodialysis.

The main question it aims to answer is: Does the use of polymethylmethacrylate (PMMA) membranes reduce the intensity of pruritus in dialysis patients?

Researchers will compare PMMA membranes to standard polysulfone-based membranes to see if PMMA works to reduce moderate-to-severe pruritis and pruritis-related quality of life.

Participants will:

* receive maintenance hemodialysis with PMMA or polysulfone membranes for 2 months; * fill in questionnaires about intensity of pruritis and its impact on daily life.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosis of CKD stage 5D, maintenance hemodialysis not less than 3 months prior screening;

Moderate-to-severe pruritis (WI-NRS score ≥ 4);

Adequate dialysis dose (spKt/V≥1,4 and/or eKt/V≥1,2);

Dialysis treatment regimen: three sessions per week of at least 4 hours duration;

Disqualifiers

Presence of active skin disease, cholestasis, severe secondary hyperparathyroidism and other conditions that, in the investigator's opinion, may be responsible for pruritus.

Noncompliance of the patient with the protocol (in the investigator's opinion).

Use of haemodiafiltration.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Polymethylmethacrylate membrane

    Device

    A polymethylmethacrylate hollow fiber membrane (PMMA membrane) has unique properties including the uniform structure and the adsorption property.

  • polysulfone membranes

    Device

    Dialyzers containing polysulfone membranes are widely used for modern dialysis therapies as they allow efficient removal of a broad spectrum of uremic toxins.

Treatment groups

62 Participants
are divided into 2 treatment groups
Group A: PMMA armExperimental treatment 1 intervention
Group B: Polysulfone armActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

5D Elman Itch Scale total score

The 5-D itch scale is a reliable, multidimensional measure of itching that has been validated in patients with chronic pruritus to able to detect changes over time. This questionnaire was designed to be useful as an outcome measure in clinical trials. The five dimensions are degree, duration, direction, disability and distribution.

Time frame
From enrollment to the end of treatment at 8 weeks

Secondary outcomes

1

WI-NRS score

24-hour Worst Itching Intensity Numerical Rating Scale

Time frame
From enrollment to the end of treatment at 8 weeks
2

Skindex-16 score

Multidimensional tool to assess pruritis

Time frame
From enrollment to the end of treatment at 8 weeks
3

Itch-MOS score

Itch-MOS questionnaire aims to evaluate impact of pruritis on sleep.

Time frame
From enrollment to the end of treatment at 8 weeks
4

5D Elman Itch Scale total score

Time frame
From the end of active treatment to the end of follow-up (4 weeks)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.